- Report
- May 2024
- 191 Pages
Global
From €2222EUR$2,500USD£1,925GBP
- Report
- February 2024
- 150 Pages
Global
From €2222EUR$2,500USD£1,925GBP
- Report
- November 2023
- 166 Pages
Global
From €2222EUR$2,500USD£1,925GBP
- Report
- July 2021
- 120 Pages
Global
From €2222EUR$2,500USD£1,925GBP
From €2222EUR$2,500USD£1,925GBP
- Report
- October 2020
- 120 Pages
Global
From €2222EUR$2,500USD£1,925GBP
- Report
- September 2025
- 150 Pages
China
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- September 2024
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- September 2024
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- November 2023
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- October 2023
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- October 2023
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- October 2023
- 150 Pages
Global
From €3422EUR$3,850USD£2,964GBP
€4311EUR$4,850USD£3,734GBP
- Report
- July 2023
- 115 Pages
Global
From €4000EUR$4,500USD£3,465GBP
- Report
- June 2025
- 250 Pages
India
From €2479EUR$2,789USD£2,148GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2479EUR$2,789USD£2,148GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2479EUR$2,789USD£2,148GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2479EUR$2,789USD£2,148GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2479EUR$2,789USD£2,148GBP
- Report
- June 2025
- 250 Pages
Japan
From €2479EUR$2,789USD£2,148GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more